文献速递生殖医学

CAV1通过Notch2信号通路调控原始卵泡形成并与人类早发性卵巢功能不全相关

CAV1 regulates primordial follicle formation via the Notch2 signalling pathway and is associated with premature ovarian insufficiency in humans.
PubMed 文献 · Hum Reprod · 2018-01-01

该研究在小鼠和HEK293细胞中探究Cav1在卵泡发育中的功能,并对200例中国POI患者和200例对照进行CAV1基因测序。Cav1缺陷导致小鼠多卵母细胞卵泡增多、Lgr5阳性细胞增殖下降,并抑制Notch2信号通路;2例POI患者携带新发CAV1突变,其中p.Glu48Gln在细胞水平影响CAV1功能和NOTCH2表达。

要点

  • Cav1缺陷小鼠卵巢多卵母细胞卵泡较对照组和对照-morpholino组增多(P < 0.01)。
  • 抑制Cav1降低Lgr5阳性细胞增殖及Lgr5和Foxl2双阳性细胞数量(P < 0.01)。
  • 200例POI患者中2例携带新发CAV1突变,其中p.Glu48Gln仅1例检出。

核心结论

  • CAV1调控小鼠生殖细胞囊破裂和原始卵泡形成,CAV1突变可能与人类早发性卵巢功能不全相关。

研究设计与样本

  • 研究在小鼠和Human Embryonic Kidney 293细胞中探究Cav1功能,卵巢每组6个随机分至Cav1-vivo-morpholino组、对照组和对照-morpholino组,所有实验重复至少三次。
  • 2012年9月至2013年12月从山东大学附属生殖医学中心招募200例中国POI女性及200例月经规律、内分泌谱正常的对照个体,对CAV1基因编码区进行测序。

主要发现

  • CAV1-vivo-morpholino诱导的小鼠卵巢Cav1缺陷导致多卵母细胞卵泡较对照组和对照-morpholino组增多(P < 0.01)。
  • 抑制Cav1降低Lgr5阳性细胞增殖(P < 0.01),并减少Lgr5和Foxl2双阳性细胞数量(P < 0.01)。
  • 抑制Cav1通过Notch2信号通路抑制卵巢上皮Lgr5阳性细胞增殖和分化。
  • 2例POI女性携带新发CAV1突变(c.45 C > G同义突变和c.142 G > C [Glu48Gln])。
  • p.Glu48Gln在HEK293FT细胞中 adversely 影响CAV1的细胞增殖功能和NOTCH2表达。

关键数值与推荐

  • Cav1缺陷组多卵母细胞卵泡多于对照组和对照-morpholino组(P < 0.01)。
  • Cav1抑制组Lgr5阳性细胞增殖低于对照(P < 0.01)。
  • Cav1抑制组Lgr5和Foxl2双阳性细胞数量少于对照(P < 0.01)。
  • 200例POI患者中2例携带CAV1突变:c.45 C > G同义突变和c.142 G > C(p.Glu48Gln)。
  • p.Glu48Gln突变在200例POI患者中仅1例检出。

临床怎么用

  • 原文结论指出,CAV1作为POI的潜在致病基因,为设计POI女性治疗方法提供了理论基础。
  • 原文未据此给出临床推荐。

局限性

  • 新发Glu48Gln突变仅在200例POI患者中的1例检出,且未能研究其在卵巢中的效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the function of CAV1 in folliculogenesis and female reproduction? SUMMARY ANSWER: CAV1 regulates germline cyst breakdown and primordial follicle (PF) formation in mice, and CAV1 mutation may be related to premature ovarian insufficiency (POI). WHAT IS KNOWN ALREADY: Pre-granulosa cells are essential for the establishment of the PF pool, which determines female fertility and reproductive lifespan. Cav1 participates in vascularization in fetal mouse ovaries. However, the role of CAV1 in early folliculogenesis and POI pathogenesis remains unclear. STUDY DESIGN, SIZE, DURATION: Cav1 function was investigated in mice and Human Embryonic Kidney 293 cells. Ovaries (six per group) were randomly assigned to Cav1-vivo-morpholino, control and control-morpholino groups, and all experiments were repeated at least three times. To investigate CAV1 mutations in women, 200 Chinese women with POI and 200 control individuals with regular menstrual cycles and normal endocrine profiles were recruited from the Center for Reproductive Medicine of Shandong University between September 2012 and December 2013. PARTICIPANTS/MATERIALS, SETTING, METHODS: Wild-type CD1 mice, Lgr5-EGFP-ires-CreERT2 (Lgr5-KI) reporter mice and Human Embryonic Kidney 293 cells were used for these experiments. Protein expression was detected by Western blot, and quantitative RT-PCR was used to detect gene expression. The expression pattern of CAV1 in mouse ovaries and the phenotype of Cav1 deficiency in mice were detected by immunofluorescence. Pre-granulosa cell proliferation in ovaries was detected by bromodeoxyuridine (BrdU) assay and immunofluorescence. The coding region of the CAV1 gene was sequenced in 200 women with POI and 200 controls. The functional effect of the novel mutation c.142 G > C (p.Glu48Gln) was investigated by Cell Counting Kit-8 (CCK8) assays and Western blot. MAIN RESULTS AND THE ROLE OF CHANCE: We confirmed that Cav1 deficiency in mouse ovary induced by CAV1-vivo-morpholino resulted in more multi-oocyte follicles than in the control and control-morpholino groups (P < 0.01). Suppression of Cav1 decreased Leucine rich repeat containing G protein coupled receptor 5 (Lgr5)-positive cell proliferation (P < 0.01) and reduced the number of Lgr5 and Forkhead box L2 (Foxl2) double-positive cells (P < 0.01). Furthermore, suppression of Cav1 inhibited ovarian epithelial Lgr5-positive cell proliferation and differentiation through the Notch2 signalling pathway. Two of the POI women carried novel CAV1 mutations (c.45 C > G synonymous and c.142 G > C [Glu48Gln]). The deleterious effect of p.Glu48Gln was corroborated by showing that it adversely affected the function of CAV1 in cell proliferation and NOTCH2 expression in HEK293FT cells. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The novel Glu48Gln mutation was only detected in one of 200 POI patients and we were unable to investigate its effects in the ovary. WIDER IMPLICATIONS OF THE FINDINGS: The identification of CAV1 as a potentially causative gene for POI provides a theoretical basis to devise treatments for POI in women. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Basic Research Program of China (973 Programs: 2012CB944700; 2013CB945501; 2013CB911400; 2014CB943202), the National Key Research and Development Program of China (2016YFC1000604, 2017YFC1001301), the State Key Program of National Natural Science Foundation of China (81430029), and the National Natural Science Foundation of China (31571540, 81522018, 81471509, 81601245, 81701406, 81571406). The authors declare no competing financial interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Huang K, Dang Y, Zhang P, et al. CAV1 regulates primordial follicle formation via the Notch2 signalling pathway and is associated with premature ovarian insufficiency in humans. Hum Reprod. 2018. PMID: 30304446. doi:10.1093/humrep/dey299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。